AVTE

Aerovate Therapeutics (AVTE)

Aerovate Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AVTE

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/22	05 : 15	GlobeNewswire Inc.	Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/05/18	08 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/05/18	05 : 59	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/05/14	05 : 57	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/05/14	05 : 39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/05/14	05 : 30	GlobeNewswire Inc.	Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/03/27	22 : 20	GlobeNewswire Inc.	Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/03/26	05 : 10	GlobeNewswire Inc.	Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/03/12	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/03/08	06 : 37	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/03/06	22 : 00	GlobeNewswire Inc.	Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/02/28	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/02/23	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/02/21	08 : 38	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/02/10	06 : 28	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/01/25	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/01/25	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/01/25	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/01/25	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/01/18	06 : 29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/01/09	07 : 11	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:AVTE	Aerovate Therapeutics Inc
2024/01/08	21 : 59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AVTE	Aerovate Therapeutics Inc
2023/12/30	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2023/12/28	07 : 50	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2023/12/23	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2023/12/21	06 : 24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2023/12/16	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2023/12/15	06 : 10	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2023/12/08	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc
2023/11/30	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AVTE	Aerovate Therapeutics Inc